The role of IL-6/JAK2/STAT3 signaling pathway in cancers
B Huang, X Lang, X Li - Frontiers in oncology, 2022 - frontiersin.org
Interleukin-6 (IL-6) is a pleiotropic cytokine involved in immune regulation. It can activate
janus kinase 2 (JAK2)-signal transducer and activator of transcription 3 (STAT3) signaling …
janus kinase 2 (JAK2)-signal transducer and activator of transcription 3 (STAT3) signaling …
Inflammation and pancreatic cancer: focus on metabolism, cytokines, and immunity
Systemic and local chronic inflammation might enhance the risk of pancreatic ductal
adenocarcinoma (PDAC), and PDAC-associated inflammatory infiltrate in the tumor …
adenocarcinoma (PDAC), and PDAC-associated inflammatory infiltrate in the tumor …
The therapeutic landscape of rheumatoid arthritis: current state and future directions
S Shams, JM Martinez, JRD Dawson, J Flores… - Frontiers in …, 2021 - frontiersin.org
Rheumatoid arthritis (RA) is a debilitating autoimmune disease with grave physical,
emotional and socioeconomic consequences. Despite advances in targeted biologic and …
emotional and socioeconomic consequences. Despite advances in targeted biologic and …
Phytochemicals in cancer cell chemosensitization: Current knowledge and future perspectives
Despite significant advancements made in the treatment of cancer during the past several
decades, it remains one of the leading causes of death worldwide killing approximately 9.6 …
decades, it remains one of the leading causes of death worldwide killing approximately 9.6 …
[HTML][HTML] IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human …
W Zhang, Y Liu, Z Yan, H Yang, W Sun… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Background We have previously discovered a relationship between the low expression of
protein tyrosine phosphatase, receptor type O (PTPRO) in tumor-infiltrating T cells and …
protein tyrosine phosphatase, receptor type O (PTPRO) in tumor-infiltrating T cells and …
[HTML][HTML] Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer
N Vainer, C Dehlendorff, JS Johansen - Oncotarget, 2018 - ncbi.nlm.nih.gov
Gastrointestinal cancer (GI) is a major health problem. Patients with gastric, pancreatic,
colorectal, bile duct and gall bladder cancer often have advanced disease at the time of …
colorectal, bile duct and gall bladder cancer often have advanced disease at the time of …
Emerging roles for the IL-6 family of cytokines in pancreatic cancer
G van Duijneveldt, MDW Griffin, TL Putoczki - Clinical science, 2020 - portlandpress.com
Pancreatic cancer has one of the poorest prognoses of all malignancies, with little
improvement in clinical outcome over the past 40 years. Pancreatic ductal adenocarcinoma …
improvement in clinical outcome over the past 40 years. Pancreatic ductal adenocarcinoma …
Methamphetamine and its immune-modulating effects
The recreational use of methamphetamine (METH, or ice) is a global burden. It pervades
and plagues contemporary society; it has been estimated that there are up to 35 million …
and plagues contemporary society; it has been estimated that there are up to 35 million …
[HTML][HTML] Ginger polysaccharide UGP1 suppressed human colon cancer growth via p53, Bax/Bcl-2, caspase-3 pathways and immunomodulation
Y Qian, C Shi, C Cheng, D Liao, J Liu… - Food Science and Human …, 2023 - Elsevier
In previous study, we got a purified ginger polysaccharide UGP1 and verified its significant
antitumor activities on colon cancer HCT116 cells. In this article, we aimed to illustrate the …
antitumor activities on colon cancer HCT116 cells. In this article, we aimed to illustrate the …
Curcumin inhibits pancreatic cancer cell invasion and EMT by interfering with tumor‑stromal crosstalk under hypoxic conditions via the IL‑6/ERK/NF‑κB axis
W Li, L Sun, J Lei, Z Wu, Q Ma… - Oncology …, 2020 - spandidos-publications.com
Hypoxic microenvironment and pancreatic stellate cells (PSCs) play important roles in
pancreatic cancer progression. PSCs secrete a number of soluble factors, such as …
pancreatic cancer progression. PSCs secrete a number of soluble factors, such as …